Page last updated: 2024-10-22

acetazolamide and Glomerulonephritis, Lupus

acetazolamide has been researched along with Glomerulonephritis, Lupus in 2 studies

Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)

Research Excerpts

ExcerptRelevanceReference
"Idiopathic intracranial hypertension is a disorder of intracerebral pressure regulation and patients run the risk of permanent visual loss."1.30Treatable intracranial hypertension in patients with lupus nephritis. ( al-Muzeiri, I; Constandi, JN; Gupta, RK; Johny, KV; Nair, MP; Nampoory, MR, 1997)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chia, XX1
Cordato, D1
Venkat, A1
Spicer, ST1
Nampoory, MR1
Johny, KV1
Gupta, RK1
Constandi, JN1
Nair, MP1
al-Muzeiri, I1

Other Studies

2 other studies available for acetazolamide and Glomerulonephritis, Lupus

ArticleYear
Intracranial hypertension in a patient with Class V lupus nephritis.
    Nephrology (Carlton, Vic.), 2019, Volume: 24, Issue:5

    Topics: Acetazolamide; Anticonvulsants; Brain; Diagnostic Techniques, Ophthalmological; Female; Glomerulonep

2019
Treatable intracranial hypertension in patients with lupus nephritis.
    Lupus, 1997, Volume: 6, Issue:7

    Topics: Acetazolamide; Adult; Anemia; Diuretics; Female; Follow-Up Studies; Furosemide; Humans; Intracranial

1997